Average Insider

Where insiders trade, we follow

$CMPS
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Healthcare
Sector
Medical - Care Facilities
Industry
Kabir Kumar Nath
CEO
166
Employees
$5.37
Current Price
$548.17M
Market Cap
52W Low$2.25
Current$5.3746.9% above low, 53.1% below high
52W High$8.90

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00---
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
No insider transactions found

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Mar 26, 2026
EPS
Estimated-$0.40
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Mar 19, 2026
EPS
Estimated-$0.40
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Feb 26, 2026
EPS
Estimated-$0.41
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Version: v26.3.33